The US FDA issued an emergency use authorization for Pfizer’s antiviral pill for home treatment of C-19 infection this Wednesday.
“Today’s authorization introduces the first treatment for COVID-19 that is in the form of a pill that is taken orally — a major step forward in the fight against this global pandemic. This authorization provides a new tool to combat COVID-19 at a crucial time in the pandemic as new variants emerge and promises to make antiviral treatment more accessible to patients who are at high risk for progression to severe COVID-19,” stated Patrizia Cacazzoni, The director of the FDA’s center for drug evaluation and research.
Join The True Defender Telegram Chanel Here: https://t.me/TheTrueDefender
Paxlovid is the first US authorized home-treatment of the C-19. It is a faster and cheaper way to treat the infection, even though the first supplies would be limited.
The press release stated that Paxlovid reduced the proportion of people with C-19 hospitalization or death by 88%.
FDA Press Release reads:
Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for Pfizer’s Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) for the treatment of mild-to-moderate coronavirus disease (COVID-19) in adults and pediatric patients (12 years of age and older weighing at least 40 kilograms or about 88 pounds) with positive results of direct SARS-CoV-2 testing, and who are at high risk for progression to severe COVID-19, including hospitalization or death. Paxlovid is available by prescription only and should be initiated as soon as possible after diagnosis of COVID-19 and within five days of symptom onset.
Paxlovid is not authorized for the pre-exposure or post-exposure prevention of COVID-19 or for initiation of treatment in those requiring hospitalization due to severe or critical COVID-19. Paxlovid is not a substitute for vaccination in individuals for whom COVID-19 vaccination and a booster dose are recommended. The FDA has approved one vaccine and authorized others to prevent COVID-19 and serious clinical outcomes associated with a COVID-19 infection, including hospitalization and death. The FDA urges the public to get vaccinated and receive a booster if eligible. Learn more about FDA-approved or -authorized COVID-19 vaccines.
Paxlovid consists of nirmatrelvir, which inhibits a SARS-CoV-2 protein to stop the virus from replicating, and ritonavir, which slows down nirmatrelvir’s breakdown to help it remain in the body for a longer period at higher concentrations. Paxlovid is administered as three tablets (two tablets of nirmatrelvir and one tablet of ritonavir) taken together orally twice daily for five days, for a total of 30 tablets. Paxlovid is not authorized for use for longer than five consecutive days.
Read more here.
Also, the antiviral pill from Merck and Co. is expected to be authorized for the same purpose as the previous drug.
Furthermore, Ivermectin is the best drug for C-19 treatment, and doctors, nurses, and C-19 patients claim that.
There have been 64 studies that show Ivermectin has an 86% success rate as prophylaxis and 67% success rate in the early treatment of the C-19.
Oklahoma doctors Dr. John Sutton and Dr. David Jayne shared their experiences with Ivermectin treatment for patients in nursing homes.
Joe Rogan stated that he recovered three days after taking monoclonal antibodies, Ivermectin, Z-pak, prednisone, IV vitamin drip.
Wayne Root successfully treated the infection in 48 hours with Ivermectin.